Question 1

Which Wall Street gurus hold Acrivon Therapeutics Inc (ACRV)?

Accepted Answer

Per the latest SEC 13F filings, 7 Wall Street gurus hold ACRV. Top holders include 짐 사이먼스 (유산), 데이비드 시겔, 블랙록, with a combined position value of about $2.0M.

Question 2

What sector does Acrivon Therapeutics Inc belong to?

Accepted Answer

Acrivon Therapeutics Inc (ACRV) is in the Biotechnology sector / Biotechnology industry, listed on NASDAQ NMS - GLOBAL MARKET.

Question 3

What are the key financial metrics for Acrivon Therapeutics Inc?

Accepted Answer

Key metrics for Acrivon Therapeutics Inc (ACRV): EPS $-2.00, Beta 1.81. Live price and chart are at the top of the page.

Question 4

What is a 13F report?

Accepted Answer

A 13F is a quarterly filing institutional investors submit to the US Securities and Exchange Commission (SEC) disclosing their equity holdings. It is mandatory for managers with at least $100M in AUM and must be filed within 45 days of the quarter end.

#	Investor	Weight	Shares	Value	Activity
1	Jim Simons (Estate) Renaissance Technologies LLC	0.00%	758,440	$1.05M	HOLD
2	Two Sigma Two Sigma Investments LP	0.00%	389,395	$541,259	HOLD
3	BlackRock BlackRock Inc	0.00%	208,939	$290,425	HOLD
4	State Street State Street Global Advisors	0.00%	67,145	$93,332	HOLD
5	Goldman Sachs Goldman Sachs Asset Management	0.00%	14,742	$20,491	HOLD
6	Fidelity (FMR) Fidelity Management & Research	0.00%	9,422	$13,097	HOLD
7	JPMorgan Chase JPMorgan Asset Management	0.00%	638	$823	HOLD

Insider	Title	Type	Shares	Value	Date
Devroe Eric	Chief Operating Officer	BUY	72,981	--	5/18/2026
Peterson Katharine	Chief Accounting Officer	BUY	14,227	--	5/18/2026

Acrivon Therapeutics Inc

Holders (7)

Insider Trades (2)

Related Articles (1)